Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-018537

Director bought 550 shares at $17.00 ($9,350)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
McLoughlin Margaret Director 2019-05-13 Purchase +550 $17.00 $9,350 550 D
Open-market purchases · 550 sh · avg $17.00 · $9,350
Loading xslF345X03/doc4.xml…